| Healthbridge Childrens's Hospital Of Houston | |
| 2929 Woodland Park Drive, Houston, Texas 77082 | |
| (281) 293-7774 | |
| Not Available |
| Name | Healthbridge Childrens's Hospital Of Houston |
|---|---|
| Type | Childrens Hospital |
| Location | 2929 Woodland Park Drive, Houston, Texas |
| Ownership | Proprietary |
| Emergency Services | No |
| Medicare ID (CCN) | 453309 |
| NPI Number | 1013968726 |
| Organization Name | HEALTHBRIDGE CHILDREN'S HOSPITAL - HOUSTON, LTD. |
| Doing Business As | NEXUS CHILDREN'S HOSPITAL - HOUSTON |
| Address | 2929 Woodland Park Dr, Houston, TX 77082 |
| Hospital Type | Chronic Disease Hospital - Children |
| Phone Number | 281-293-7774 |
News Archive
First suicide attempts are more lethal than previously realized, reports a study of children and adolescents published in the Journal of the American Academy of Child and Adolescent Psychiatry.
Using CRISPR/Cas9 and human intestinal organoids to study genes implicated in the biology of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), researchers from the Netherlands identified a specific serine protease (TMPRSS2) as an attractive pan-coronavirus therapeutic target. Their exciting findings are available in a study currently available on the bioRxiv* preprint server.
A joint research effort by the Hospital and the Instituto de Investigación Germans Trias i Pujol is characterizing and studying a new cohort of cardiogenic shock patients to predict the risk of having this heart attack-derived complication which, while infrequent, sometimes presents a fatal outcome.
A study in the Sept. 1 issue of the journal Sleep shows that teens who slept less than eight hours per weeknight ate higher proportions of fatty foods and snacks than adolescents who slept eight hours or more. The results suggest that short sleep duration may increase obesity risk by causing small changes in eating patterns that cumulatively alter energy balance, especially in girls.
Arvinas LLC, a private biotechnology company creating a new class of drugs based on protein degradation, announced a strategic collaboration with Merck, known as MSD outside of the United States and Canada, in which Arvinas' novel PROTAC technology will be used to degrade target proteins, with the goal of creating novel therapeutics.
› Verified 9 days ago
| Able to receive lab results electronically | Not Available |
| Able to track patients' lab results, tests, and referrals electronically between visits | Not Available |
News Archive
First suicide attempts are more lethal than previously realized, reports a study of children and adolescents published in the Journal of the American Academy of Child and Adolescent Psychiatry.
Using CRISPR/Cas9 and human intestinal organoids to study genes implicated in the biology of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), researchers from the Netherlands identified a specific serine protease (TMPRSS2) as an attractive pan-coronavirus therapeutic target. Their exciting findings are available in a study currently available on the bioRxiv* preprint server.
A joint research effort by the Hospital and the Instituto de Investigación Germans Trias i Pujol is characterizing and studying a new cohort of cardiogenic shock patients to predict the risk of having this heart attack-derived complication which, while infrequent, sometimes presents a fatal outcome.
A study in the Sept. 1 issue of the journal Sleep shows that teens who slept less than eight hours per weeknight ate higher proportions of fatty foods and snacks than adolescents who slept eight hours or more. The results suggest that short sleep duration may increase obesity risk by causing small changes in eating patterns that cumulatively alter energy balance, especially in girls.
Arvinas LLC, a private biotechnology company creating a new class of drugs based on protein degradation, announced a strategic collaboration with Merck, known as MSD outside of the United States and Canada, in which Arvinas' novel PROTAC technology will be used to degrade target proteins, with the goal of creating novel therapeutics.
› Verified 9 days ago
St Joseph Medical Center Acute Care Hospital Location: 1401 St. Joseph Parkway, Houston, Texas 77002 Phone: (713) 757-1000 | |
Memorial Hermann - Texas Medical Center Acute Care Hospital Location: 6411 Fannin, Houston, Texas 77030 Phone: (713) 704-3700 | |
Memorial Hermann Hospital System Acute Care Hospital Location: 1635 North Loop West, Houston, Texas 77008 Phone: (713) 448-6796 | |
Chi St Luke's Health Baylor College Of Medicine Me Acute Care Hospital Location: 6720 Bertner, Houston, Texas 77030 Phone: (832) 355-1000 | |
Harris Health System Acute Care Hospital Location: 2525 Holly Hall, Houston, Texas 77054 Phone: (713) 566-6417 | |
Houston Methodist Hospital Acute Care Hospital Location: 6565 Fannin, Houston, Texas 77030 Phone: (713) 790-2221 |